BMJ 1996;312:273-276 (3 February)

Papers

Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial

E Lidbrink, ,a J Elfving, ,b J Frisell, ,a E Jonsson,  c

a South Hospital, Stockholm, Sweden, b Swedish Council on Technology Assessment in Health Care, Stockholm, c Karolinska Institute, Department of Medicine, Huddinge University Hospital, Stockholm

Correspondence to: Dr E Lidbrink, Department of Oncology, Sodersjukhuset, S-118 83 Stockholm, Sweden.

Abstract

Objectives: To examine the implications of false positive results of mammography in terms of the time lag from screening and complete mammography to the point when women with false positive results are declared free of cancer; the extra examinations, biopsies, and check ups required; and the cost of these extra procedures.
Design: Review of women with false positive results from the Stockholm mammography screening trial.
Setting: Department of Oncology, South Hospital, Stockholm.
Subjects: 352 and 150 women with false positive results of mammography from the first and second screening rounds of the Stockholm trial.
Main outcome measures: Extra examinations and investigations required and the cost of these procedures.
Results: The 352 women from the first screening round made 1112 visits to the physician and had 397 fine needle aspiration biopsies, 187 mammograms, and 90 surgical biopsies before being declared free of cancer. After six months 64% of the women (219/342) were declared cancer free. The 150 women in the second round made 427 visits to the physician and had 145 fine needle aspiration biopsies, 70 mammograms, and 28 surgical biopsies, and after six months 73% (107/147) were declared cancer free. The follow up costs of the false positive screening results were Kr2.54m (pounds sterling250000) in the first round and Kr0.85m (pounds sterling84000) in the second round. Women under 50 accounted for about 41% of these costs.
Conclusions: The examinations and investigations carried out after false positive mammography--especially in women under 50--and the cost of these procedures are a neglected but substantial problem.

Key messages

  • Key messages

  • These extra costs come from the examinations and investigations required during follow up--for example, repeated biopsy of benign tissue--before the patient is declared cancer free

  • In this series the costs of following up women with false positive mammograms were almost one third of the cost of screening all women in the randomised Stockholm mammography trial

  • These extra costs and other negative aspects of false positive results of mammography--especially in women under 50--are a neglected but substantial problem

  • The benefits of mammography must be carefully weighed against the potential negative aspects, especially in women under 50


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

False positive findings of mammography will have psychological consequences
I S Tobias and Michael Baum
BMJ 1996 312: 1227. [Extract] [Full Text]

This article has been cited by other articles:

  • Brewer, N. T., Salz, T., Lillie, S. E. (2007). Systematic Review: The Long-Term Effects of False-Positive Mammograms. ANN INTERN MED 146: 502-510 [Abstract] [Full text]  
  • Armstrong, K., Moye, E., Williams, S., Berlin, J. A., Reynolds, E. E. (2007). Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians. ANN INTERN MED 146: 516-526 [Abstract] [Full text]  
  • Blanchard, K., Colbert, J. A., Kopans, D. B., Moore, R., Halpern, E. F., Hughes, K. S., Smith, B. L., Tanabe, K. K., Michaelson, J. S. (2006). Long-term Risk of False-Positive Screening Results and Subsequent Biopsy as a Function of Mammography Use.. Radiology 240: 335-342 [Abstract] [Full text]  
  • Castells, X., Molins, E., Macia, F. (2006). Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme.. J. Epidemiol. Community Health 60: 316-321 [Abstract] [Full text]  
  • Ghosh, K., Melton, L. J. III, Suman, V. J., Grant, C. S., Sterioff, S., Brandt, K. R., Branch, C., Sellers, T. A., Hartmann, L. C. (2005). Breast Biopsy Utilization: A Population-Based Study. Arch Intern Med 165: 1593-1598 [Abstract] [Full text]  
  • Lafata, J. E., Simpkins, J., Lamerato, L., Poisson, L., Divine, G., Johnson, C. C. (2004). The Economic Impact of False-Positive Cancer Screens. Cancer Epidemiol. Biomarkers Prev. 13: 2126-2132 [Abstract] [Full text]  
  • Cullen, J., Schwartz, M. D., Lawrence, W. F., Selby, J. V., Mandelblatt, J. S. (2004). Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life. JCO 22: 943-952 [Abstract] [Full text]  
  • Smith, R. A., Saslow, D., Andrews Sawyer, K., Burke, W., Costanza, M. E., Evans, W. P. III, Foster, R. S. Jr., Hendrick, E., Eyre, H. J., Sener, S. (2003). American Cancer Society Guidelines for Breast Cancer Screening: Update 2003. CA Cancer J Clin 53: 141-169 [Abstract] [Full text]  
  • Humphrey, L. L., Helfand, M., Chan, B. K.S., Woolf, S. H. (2002). Breast Cancer Screening: A Summary of the Evidence for the U.S. Preventive Services Task Force. ANN INTERN MED 137: 347-360 [Abstract] [Full text]  
  • Lorant, V, Boland, B, Humblet, P, Deliege, D (2002). Equity in prevention and health care. J. Epidemiol. Community Health 56: 510-516 [Abstract] [Full text]  
  • Pisano, E. D., Fajardo, L. L., Caudry, D. J., Sneige, N., Frable, W. J., Berg, W. A., Tocino, I., Schnitt, S. J., Connolly, J. L., Gatsonis, C. A., McNeil, B. J. (2001). Fine-Needle Aspiration Biopsy of Nonpalpable Breast Lesions in a Multicenter Clinical Trial: Results from the Radiologic Diagnostic Oncology Group V. Radiology 219: 785-792 [Abstract] [Full text]  
  • Christiansen, C. L., Wang, F., Barton, M. B., Kreuter, W., Elmore, J. G., Gelfand, A. E., Fletcher, S. W. (2000). Predicting the Cumulative Risk of False-Positive Mammograms. JNCI J Natl Cancer Inst 92: 1657-1666 [Abstract] [Full text]  
  • Schwartz, L. M, Woloshin, S., Sox, H. C, Fischhoff, B., Welch, H G. (2000). US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. BMJ 320: 1635-1640 [Abstract] [Full text]  
  • Pisano, E. D. (2000). Current Status of Full-Field Digital Mammography1. Radiology 214: 26-28 [Full text]  
  • Fletcher, S. W. (1999). False-Positive Screening Mammograms: Good News, but More To Do. ANN INTERN MED 131: 60-62 [Full text]  
  • Elmore, J. G., Barton, M. B., Moceri, V. M., Polk, S., Arena, P. J., Fletcher, S. W. (1998). Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations. NEJM 338: 1089-1096 [Abstract] [Full text]  
  • Fletcher, S. (1997). Breast cancer screening in women aged under 50. BMJ 314: 764-764 [Full text]  
  • Tobias, I S, Baum, M. (1996). False positive findings of mammography will have psychological consequences. BMJ 312: 1227-1227 [Full text]  
  • Tomkinson, A. (1996). Daily measurements of temperature should have been used. BMJ 312: 1227b-1227 [Full text]  
Doc2Doc Vacancy
Access jobs at BMJ Careers
Whats new online at Student BMJ